HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morbidity in infants with antenatally-diagnosed anterior abdominal wall defects.

Abstract
The aims of this study were to compare the morbidity of infants with gastroschisis (GS) with that of infants with exomphalos (EX) without lethal abnormalities and to identify factors predictive of adverse outcome: a requirement for parenteral nutrition (PN) for over 1 month and hospital admission for over 2 months. The medical records of 45 infants with anterior wall defects (32 with GS) diagnosed antenatally who consecutively received intensive care in one institution from 1993 were reviewed. Both the GS and EX infants had a median gestational age of 37 weeks, but the former were lighter at birth (P < 0.01). Fourteen infants (all with GS) were able to start feeds only after 2 weeks; 10 (8 with GS) developed liver dysfunction; and 5 (all with GS) died. The GS compared to the EX infants required a longer period of PN (median 20 vs 10 days, P < 0.01) and longer hospital admission (median 40 vs 25 days, P < 0.01). In the GS group the time to start feeding related independently to prolonged hospital stay, and the existence of structural bowel abnormalities (SBA) related independently to both measures of adverse outcome, with a positive predictive value of 100%. We conclude that infants with GS, particularly those with SBA, suffer greater morbidity than infants with EX without lethal abnormalities.
AuthorsG Dimitriou, A Greenough, J S Mantagos, M Davenport, K H Nicolaides
JournalPediatric surgery international (Pediatr Surg Int) Vol. 16 Issue 5-6 Pg. 404-7 ( 2000) ISSN: 0179-0358 [Print] Germany
PMID10955574 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Enteral Nutrition
  • Female
  • Gastroschisis (complications, diagnosis, mortality, therapy)
  • Gestational Age
  • Hernia, Umbilical (complications, diagnosis, mortality, therapy)
  • Humans
  • Infant, Newborn
  • Length of Stay (statistics & numerical data)
  • Male
  • Morbidity
  • Prenatal Diagnosis
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: